中医药治疗免疫性血小板减少症的机制研究进展
首发时间:2016-08-12
摘要:免疫性血小板减少症(ITP) 是一种免疫介导的血小板破坏增多、血小板生成不足,以皮肤粘膜出血为特征的自身免疫性疾病。现代中西医血液病专家共识将ITP的中医病名命名为"紫癜病"。近年来,中医药治疗ITP的机制研究从临床到动物实验研究取得一些进展,本文就中医药干预ITP的临床及实验研究进行总结分析,为评价中医药治疗ITP的作用机制及新药研发提供参考。
关键词: 免疫性血小板减少症 紫癜病 中医药 病因病机 研究进展
For information in English, please click here
Research progress on the mechanism of Traditional Chinese medicine in the treatment of immune thrombocytopenia
Abstract:Immune thrombocytopenia is an autoimmune disorder characterized by increased platelet destruction and decreased platelet production and mucocutaneous bleeding. Consensus of Chinese and Western medicine Hematology experts on the disease name of Chinese Medicine of ITP is named as "Purpura disease".In recent years, there has made some progress on the mechanism of TCM in the treatment of ITP in clinical and animal experimental research.In this paper, the clinical and experimental study of TCM in the treatment of ITP were analyzed and summarized,which provide a reference for evaluate the mechanism of TCM in the treatment of ITP and new drugs research and development..
Keywords: Immune thrombocytopenia Purpura disease Traditional Chinese medicine Etiology and pathogenesis Research progress?
论文图表:
引用
No.4701432366944146****
同行评议
共计0人参与
勘误表
中医药治疗免疫性血小板减少症的机制研究进展
评论
全部评论0/1000